Pascal Touchon is the President, Chief Executive Officer, and a member of the Board of Directors at Atara Biotherapeutics.
Pascal Touchon is the President, Chief Executive Officer, and a member of the Board of Directors at Atara Biotherapeutics. The company is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. Touchon has over 30 years of global biopharmaceutical leadership experience, previously serving as Global Head, Cell & Gene at Novartis Oncology, where he was responsible for the global launch of KYMRIAH®.
Full founder directory · Investor directory · Company funding database · Fundraising library